This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Eberhard-Karls-Universitaet Tuebingen Universitaetsklinikum. Active years: 2010.
Company Filing History:
Years Active: 2010
Title: The Innovations of Ingrid Albert
Introduction
Ingrid Albert is a notable inventor based in Tübingen, Germany. She has made significant contributions to the field of biotechnology, particularly in the development of monoclonal antibodies. Her work focuses on the Frizzled receptor family, which plays a crucial role in various biological processes.
Latest Patents
Ingrid Albert holds a patent for a monoclonal antibody against the Frizzled receptor 4. This invention relates to a monoclonal antibody or fragment that specifically binds to human receptors of the Frizzled (FZD) family. The patent also includes a hybridoma cell that produces the antibody. Additionally, it outlines methods for detecting and isolating FZD receptors in biological samples, as well as the use of the antibody for specific detection and isolation purposes. This innovation has potential applications in both research and clinical settings.
Career Highlights
Throughout her career, Ingrid Albert has worked at prestigious institutions, including Eberhard-Karls-Universität Tübingen and Universitätsklinikum Tübingen. Her research has contributed to advancements in understanding the Frizzled receptor family and its implications in health and disease.
Collaborations
Ingrid has collaborated with esteemed colleagues such as Hans-Joerg Buehring and Sigrid Hojak. These partnerships have enhanced her research and expanded the impact of her innovations.
Conclusion
Ingrid Albert's work exemplifies the importance of innovation in biotechnology. Her contributions to the development of monoclonal antibodies against the Frizzled receptor family highlight her role as a leading inventor in her field.